entertainment -WSS

entertainment

author：Wikipedia 2025-09-27 19:37:10 - browse：8

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Today, we explore the future of obesity drugs and how they’re named, we chat with CRISPR pioneers about what it’s like to see the technology approved for human use, and more.

The need-to-know this morning:
• Bayer said it prematurely stopped a Phase 3 study in stroke prevention after independent monitors concluded its experimental blood-thinning medicine, called asundexian, showed inferior efficacy compared to a standard treatment. The asundexian study setback is a significant blow to Bayer’s effort to revamp its drug-development pipeline, analysts said.
• Carmot Therapeutics filed paperwork Friday for an initial public offering of undisclosed size. The Berkeley, Calif.-based company is developing drugs that target GLP-1 and GIP to treat diabetes and obesity, similar to Novo Nordisk’s Ozempic/Wegovy and Eli Lilly’s Mounjaro/Zepbound.
• Bristol Myers Squibb and 2Seventy Bio said the FDA will not complete an on-time review of its application seeking to expand the use of Abecma, their CAR-T therapy for multiple myeloma. Instead, the FDA will convene an advisory panel meeting — date to be determined — to examine survival data from an Abecma clinical trial.
• The U.K. and the pharmaceutical industry have reached a deal on a five-year plan outlining how the health system pays for drugs, as the country tries to keep a lid on its medicines spending while simultaneously building up its life sciences industry. STAT’s Andrew Joseph has more here.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Congress likely to miss an opportunity to fix drug shortages issue

Wikipedia

WSS

FDA warns medical device makers about rise in fabricated data

Elon Musk says Twitter has 'negative cash flow' and 'heavy debt'

Measles policy set amid Florida outbreak alarms vaccine proponents

MD Anderson's Padmanee Sharma responds to research credit suit

Medicare Advantage enrollment grows 7.1% to 33.4 million people

As AI regulations shape up, health tech startups beg for clarity

hotspot

entertainment

entertainment

How one medical school became remarkably diverse

Reporting on presidential health from Reagan to Trump and Biden

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

How one medical school became remarkably diverse

J&J expands global access to TB drug amid advocacy campaign

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Weight loss drugs aren’t covered by Obamacare. That may change

How to save PrEP access — and even expand it

Woman gored by Bison at Yellowstone

entertainment

Special counsel informs Trump he is target in probe of efforts to overturn 2020 election

RFK Jr. accused of antisemitic claims about COVID but insists he was misunderstood

Grail faces three suits alleging harassment, retaliation

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

4 killed in mass shooting in Georgia, shooter remains on the loose: Police

Grail faces three suits alleging harassment, retaliation

entertainment

Wikipedia

knowledge

focus